BCL2L14 and inflammatory bowel disease: Because of this immunomodulatory role in activated epithelia, our data suggest that isoform-specific changes in BCL-G expression in IBD and colorectal cancer may therefore reflect and perhaps contribute to altered immune signatures in these disease states.